In a 12‑week pregnant patient with a retroverted uterus and multiple uterine fibroids who has failed bladder training and has had an indwelling urethral catheter for 6 days, what management steps should I, as the obstetrician‑gynecologist, take while coordinating care with a urogynecologist?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 17, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Management of Acute Urinary Retention in 12-Week Pregnancy with Retroverted Uterus and Fibroids

Remove the indwelling catheter immediately and attempt manual reduction of the incarcerated retroverted uterus using the knee-chest position, followed by intermittent catheterization if reduction is successful. After 6 days of continuous catheterization, you are at significant risk for urinary tract infection and long-term bladder dysfunction, and the catheter itself may be preventing spontaneous uterine repositioning 1, 2.

Immediate Actions (Next 24-48 Hours)

Step 1: Bladder Management

  • Remove the indwelling catheter now – prolonged catheterization (>6 days) increases infection risk and prevents assessment of whether the obstruction has resolved 3
  • Perform post-void residual measurement immediately after removal
  • If retention persists, use clean intermittent catheterization (CIC) every 4-6 hours rather than replacing an indwelling catheter 4
  • Monitor first void timing and volume meticulously 3

Step 2: Attempt Conservative Uterine Reduction

The retroverted uterus with fibroids is likely incarcerated between the sacral promontory and pubic symphysis, causing bladder outlet obstruction 1, 2.

Reduction maneuvers to attempt:

  1. Knee-chest position: Have patient assume this position for 10-15 minutes, 3-4 times daily 5, 2
  2. Downward-facing dog yoga position: Alternative positioning that has shown success 5
  3. Manual reduction: With empty bladder, attempt gentle bimanual examination to elevate the fundus out of the pelvis 2, 6
  4. Trendelenburg positioning: May facilitate spontaneous reduction

Step 3: Coordinate Imaging

  • Obtain transvaginal ultrasound to assess:
    • Exact uterine position and degree of retroversion
    • Fibroid size, number, location (especially posterior/fundal fibroids causing incarceration)
    • Bladder wall thickness (chronic retention causes detrusor damage)
    • Fetal viability at 12 weeks 1, 2

If Conservative Measures Fail (48-72 Hours)

Surgical Intervention Criteria

If after 48-72 hours of positioning, intermittent catheterization, and attempted manual reduction the patient still cannot void:

Escalation pathway:

  1. Cystoscopy under anesthesia with attempted manual reduction – anesthesia allows pelvic floor relaxation that may permit reduction 6
  2. Laparoscopic or open surgical reduction – last resort if manual reduction impossible 6
  3. Consider myomectomy only if a specific pedunculated or posterior fibroid is clearly causing mechanical incarceration and cannot be reduced 6

Critical warning: Surgery in first trimester with incarcerated uterus carries 15-20% miscarriage risk 6. However, untreated incarceration risks uremia, renal failure, sepsis, uterine rupture, and maternal/fetal death 1.

Ongoing Management After Successful Reduction

Bladder Rehabilitation

  • Continue intermittent catheterization if post-void residuals >100-150 mL 3
  • Measure residuals after each void for first week
  • Gradually space catheterizations as residuals decrease
  • Avoid indwelling catheter – if absolutely necessary, remove within 12 hours and use fluid balance charts 3, 4

Prevent Re-incarceration

  • Maintain knee-chest position 10-15 minutes twice daily through 16 weeks gestation 5
  • Serial ultrasounds every 2 weeks until 16-18 weeks to confirm uterus has risen out of pelvis
  • Most retroverted uteri spontaneously antevert by 14-16 weeks as uterus enlarges 2, 7

Monitor for Complications

  • Weekly assessment for signs of re-incarceration: inability to void, suprapubic pain, overflow incontinence
  • Temperature monitoring – fever suggests UTI from retention 8
  • Fetal surveillance – incarceration increases preterm labor risk 9

Urogynecology Consultation Role

The urogynecologist's preoperative assessment is warranted because:

  • Anticipated difficult surgery: Multiple fibroids with retroverted uterus increases risk of uterine injury, bleeding, and need for hysterectomy if reduction fails 6
  • Bladder assessment: Chronic retention may have caused detrusor dysfunction requiring specialized management
  • Surgical planning: If myomectomy needed, urogyne can assess for concurrent bladder/ureteral injury risk

However, do not delay conservative management waiting for urogyne consultation – attempt positioning and intermittent catheterization immediately 1, 2.

Common Pitfalls to Avoid

  1. Leaving indwelling catheter in place – this is the most common error. The catheter prevents assessment of resolution and increases infection risk exponentially after 5-7 days 3, 4

  2. Assuming this is "normal pregnancy hydronephrosis" – at 12 weeks, physiologic hydronephrosis has not yet developed. Inability to void = mechanical obstruction requiring intervention 9, 2

  3. Delaying reduction attempts – every day of incarceration increases risk of permanent bladder damage, renal impairment, and pregnancy loss 1, 6

  4. Jumping to surgery prematurely – 70-80% of cases resolve with conservative positioning and intermittent catheterization 2, 6

  5. Ignoring the fibroids – posterior or fundal fibroids significantly reduce success of conservative management and may require surgical intervention 6, 10

Related Questions

How should a 12‑week pregnant patient with an incarcerated retroverted uterus and urinary retention be managed?
Should a urogynecologist be consulted for a 12‑week pregnant patient with urinary retention who has failed bladder‑training measures and whose urologist recommended using a Uriflow monitoring device?
What are the causes of urinary retention in pregnancy?
How can an incarcerated retroverted uterus at 12 weeks gestation with multiple myomas be repositioned?
What is the management for acute urinary retention in a pregnant woman at 13 weeks gestation?
How should I manage a 44-year-old male with hypercholesterolemia, hypertriglyceridemia, prediabetes (hemoglobin A1c 6.6%), elevated transaminases (aspartate aminotransferase 65 U/L, alanine aminotransferase 82 U/L), and consuming 11 alcoholic drinks per week?
What is the appropriate evaluation and management for a patient presenting with bradykinesia?
What is the absolute neutrophil count (ANC) goal for febrile neutropenia in pediatric and adult patients?
How can a patient stable on oral risperidone 5 mg daily be switched to a long‑acting injectable formulation (e.g., Risperdal Consta or Perseris)?
How should I manage a 43-year-old man with 4 days of left lower quadrant pain and scant painless bright red rectal bleeding, tenderness to palpation in the left lower quadrant, a normal abdominal exam, and no systemic symptoms?
What is the most likely diagnosis and recommended management for a patient with leukocytosis (WBC 14.6 K/µL) due to neutrophilia (absolute neutrophil count 11.5 ×10³/µL) and borderline monocytosis, normal red blood cell indices, and HbA1c 5.6%?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.